Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Boeing stock gaps down 8.50% on new round of 737 Max woes: https://www.marketbeat.com/logos/articles/med_20240108114018_boeing-stock-gaps-down-8.jpg
Boeing stock gaps down 8.50% on new round of 737 Max woes

Shares of The Boeing Co. (NYSE: BA) gapped down 8.50% at the open on January 8, after a panel from an Alaska Air Group Inc. (NYSE: ALK) fell out mid-flight. 

The plane made an emergency landing

Merck, the Dow's hottest stock, gets set to report Q4 financials: https://www.marketbeat.com/logos/articles/med_20240118082845_merck-the-dows-hottest-stock-gets-set-to-report-q4.jpg
Merck, the Dow's hottest stock, gets set to report Q4 financials

Dow Jones Industrial Average (DJIA) stalwart Merck & Co., Inc. (NYSE:MRK) has momentum on its side heading into its February 1st earnings report. 

Shares of the large cap pharmaceutical company

Voyager Therapeutics stock pops 30% on deal with Novartis: https://www.marketbeat.com/logos/articles/med_20240108080612_voyager-therapeutics-pops-30-on-gene-therapy-deal.jpg
Voyager Therapeutics stock pops 30% on deal with Novartis

Voyager Therapeutics Inc. (NASDAQ: VYGR) is a biotech in the medical sector that specializes in gene therapy for neurological diseases. Its shares took a 30% spike on news of its partnership with

Chipotle stock price can set a new all-time high in 2024: https://www.marketbeat.com/logos/articles/med_20240108074725_chart-cmg-182024ver001.png
Chipotle stock price can set a new all-time high in 2024

Chipotle Mexican Grill (NYSE: CMG) shares entered correction along with the broader market at the start of 2024, but the pullback will not likely get far. The company continues to execute at the

Spirit AeroSystems stock will rally on Boeing's new orders: https://www.marketbeat.com/logos/articles/med_20240108075454_spirit-aerosystems-stock-will-rally-on-boeings-new.jpg
Spirit AeroSystems stock will rally on Boeing's new orders

Everyone is focused on the popularity of following Boeing (NYSE: BA) and its recent development in new orders. After years of being compressed below any reasonable fairness, its stock is finally

Spirit AeroSystems stock will rally on Boeing's new orders: https://www.marketbeat.com/logos/articles/med_20240108075454_spirit-aerosystems-stock-will-rally-on-boeings-new.jpg
Spirit AeroSystems stock will rally on Boeing's new orders

Everyone is focused on the popularity of following Boeing (NYSE: BA) and its recent development in new orders. After years of being compressed below any reasonable fairness, its stock is finally

Apple stock at a crossroads, is now the time to buy?: https://www.marketbeat.com/logos/articles/med_20240108074512_apple-stock-at-a-crossroads-is-now-the-time-to-buy.jpg
Apple stock at a crossroads, is now the time to buy?

Apple Inc. (NASDAQ: AAPL) stands as a towering figure in the world of stocks and investments, a testament to the power of innovation and resilience in the tech industry. However, recent price

Bank of America and Citigroup are banking stocks that could soar: https://www.marketbeat.com/logos/articles/med_20240108073632_bank-of-america-and-citigroup-are-banking-stocks-c.jpg
Bank of America and Citigroup are banking stocks that could soar

Who likes to invest in financial stocks? Only people with a solid financial or accounting background, since they can reasonably understand the balance sheets and valuations of these stocks well

Apple stock at a crossroads, is now the time to buy?: https://www.marketbeat.com/logos/articles/med_20240108074512_apple-stock-at-a-crossroads-is-now-the-time-to-buy.jpg
Apple stock at a crossroads, is now the time to buy?

Apple Inc. (NASDAQ: AAPL) stands as a towering figure in the world of stocks and investments, a testament to the power of innovation and resilience in the tech industry. However, recent price

Apple stock at a crossroads, is now the time to buy?: https://www.marketbeat.com/logos/articles/med_20240108074512_apple-stock-at-a-crossroads-is-now-the-time-to-buy.jpg
Apple stock at a crossroads, is now the time to buy?

Apple Inc. (NASDAQ: AAPL) stands as a towering figure in the world of stocks and investments, a testament to the power of innovation and resilience in the tech industry. However, recent price

Apple stock at a crossroads, is now the time to buy?: https://www.marketbeat.com/logos/articles/med_20240108074512_apple-stock-at-a-crossroads-is-now-the-time-to-buy.jpg
Apple stock at a crossroads, is now the time to buy?

Apple Inc. (NASDAQ: AAPL) stands as a towering figure in the world of stocks and investments, a testament to the power of innovation and resilience in the tech industry. However, recent price

Peloton Stock surges on TikTok deal...can it keep up the pace?: https://www.marketbeat.com/logos/articles/med_20240108071707_peloton-stock-surges-on-tiktok-deal.jpg
Peloton Stock surges on TikTok deal...can it keep up the pace?

In an attempt to revive its stagnant subscriber base, Peloton Interactive, Inc. (NASDAQ:PTON) is turning to TikTok.

Last week, the connected fitness company announced its own connection with the

2 low-priced gene therapy stocks to speculate on: https://www.marketbeat.com/logos/articles/med_20240107112838_chart-sgmo.jpg
2 low-priced gene therapy stocks to speculate on

Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic differences. Gene-editing involves using

2 low-priced gene therapy stocks to speculate on: https://www.marketbeat.com/logos/articles/med_20240107112838_chart-sgmo.jpg
2 low-priced gene therapy stocks to speculate on

Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic differences. Gene-editing involves using

HCA Healthcare Rallies: Weight-loss drugs really a big threat?: https://www.marketbeat.com/logos/articles/med_20240107185912_hca-healthcare-rallies-weight-loss-drugs-really-a.jpg
HCA Healthcare Rallies: Weight-loss drugs really a big threat?

Hospital chain HCA Healthcare, Inc. (NYSE: HCA) has been working on a bullish base and even managed to post gains in a week when the SPDR S&P 500 ETF Trust (NYSEARCA: SPY) pulled back. 

Investors

3 Magnificent Seven stocks are approaching potential buy zones: https://www.marketbeat.com/logos/articles/med_20240107184322_3-magnificent-seven-stocks-are-approaching-potenti.jpg
3 Magnificent Seven stocks are approaching potential buy zones

As the year begins and capital begins to be put to work, a new chapter is unfolding for members of the heralded 'Magnificent Seven.' As the curtains rise in 2024, these tech behemoths, the guiding

3 Magnificent Seven stocks are approaching potential buy zones: https://www.marketbeat.com/logos/articles/med_20240107184322_3-magnificent-seven-stocks-are-approaching-potenti.jpg
3 Magnificent Seven stocks are approaching potential buy zones

As the year begins and capital begins to be put to work, a new chapter is unfolding for members of the heralded 'Magnificent Seven.' As the curtains rise in 2024, these tech behemoths, the guiding

3 Magnificent Seven stocks are approaching potential buy zones: https://www.marketbeat.com/logos/articles/med_20240107184322_3-magnificent-seven-stocks-are-approaching-potenti.jpg
3 Magnificent Seven stocks are approaching potential buy zones

As the year begins and capital begins to be put to work, a new chapter is unfolding for members of the heralded 'Magnificent Seven.' As the curtains rise in 2024, these tech behemoths, the guiding

Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. Neuer 200% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73176/AC-080124.001.png
Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. Neuer 200% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. 200% Biotech Hot Stock nach 134.452% mit Biogen

 

08.01.24 08:03

AC Research

 

London (www.aktiencheck.de , Anzeige)

 

Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. Neuer 200% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73176/AC-080124.001.png
Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. Neuer 200% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. 200% Biotech Hot Stock nach 134.452% mit Biogen

 

08.01.24 08:03

AC Research

 

London (www.aktiencheck.de , Anzeige)

 

Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. Neuer 200% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73176/AC-080124.001.png
Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. Neuer 200% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. 200% Biotech Hot Stock nach 134.452% mit Biogen

 

08.01.24 08:03

AC Research

 

London (www.aktiencheck.de , Anzeige)

 

MarketBeat ‘Stock of the Week’: Bowlero is on a roll: https://www.marketbeat.com/logos/articles/20240106082302_bowl5.png
MarketBeat ‘Stock of the Week’: Bowlero is on a roll

Some stocks are benefitting from the market’s ‘risk-on’ surge more than others — and Bowlero Corp. (NYSE: BOWL) is one of them.

Over the past two months, shares of the world’s largest bowling

Are defensive sectors ready to outshine growth in 2024?: https://www.marketbeat.com/logos/articles/med_20240105132256_are-defensive-sectors-ready-to-outshine-growth-in.jpg
Are defensive sectors ready to outshine growth in 2024?

Defensive sectors are off to a better start to the new year than growth stocks, which dominated in 2023. 

The Health Care Select Sector SPDR Fund (NYSEARCA: XLV), which has both growth and